{Title}

Bio€quity Europe | 2019

20th Annual Bio€quity Europe



May 20 - 21, 2019 | Barcelona


The 20th Bio€quity Europe : Hot Topics, Hot Spots

Biotech is entering a golden age. The world is seeing a flood of new therapies that have long been the promise of this industry.

Gene Therapies.  Stem Cell Treatments.  Antisense.  siRNA.  CAR T.

Is Europe playing its part?

Are they holding their own in inventing the next-generation of therapies and technologies?

And is Europe creating hot beds of innovation to lead the way forward?

For 20 years, Bio€quity Europe has been holding up a mirror to reflect Europe’s progress in the biotech revolution.

Today, even more exciting science and technologies are on the horizon. But the momentum is global. Europe must keep pace to attract the best talent and investment, create jobs and improve public health.

In 2019, Bio€quity Europe gathers European “Hot Topics” companies and their investors to measure their progress and debate the path forward.

For 20 years, Bio€quity Europe has showcased more than 800 leading European companies to thousands of investment and pharma business development professionals. Delegates from 24 nations attended Bio€quity Europe last year in Ghent.

Presenting Company slots running out. Click here to nominate your company.


Return to Conferences List
SCHEDULE
Sunday, May 19, 2019

19:00  to  21:00
Welcome Reception
Crowne Plaza Barcelona Fira Center - Terraza Montjuic
Monday, May 20, 2019

09:00  to  09:25
Offical Greetings from the Hosts
Room - Rubí + Zafir (level -1)
09:25  to  09:30
Euronext Opening Bell Ceremony
Room - Rubí + Zafir (level -1)
09:30  to  10:15
Opening Plenary Session
Room - Rubí + Zafir (level -1)
Hot Topics, Hot Spots
Biotech is entering a golden age. Gene therapies. Stem cell treatments. Antisense. siRNA. CAR T. They are today’s “Hot Topics.” Is Europe playing its part? And is it creating “Hot Spots” of innovation to lead the way forward? And how Europe must keep pace to attract the best talent and investment, create jobs and improve public health? For its 20th anniversary, Bio€quity Europe begins with “Biotech in Europe: Scaling Innovation," an exclusive report Knowledge Partner McKinsey & Co. Based on a survey of industry KOLs, this report will provide food for discussion on such key questions as:
• Are Europe’s biotech hotspots playing their part in global biotech innovation?
• The great European biotech funding evolution: Where next?
• How can CEOs and investors best play their cards in this context?

10:15  to  11:00
European Leaders Respond
Room - Rubí + Zafir (level -1)
Where Can Europe Lead?
A cross-section of entrepreneurs, researchers and investors debate the McKinsey findings and identify where Europe can create global impact in genetic and genomic medicine, novel modalities, next-generation manufacturing, and digital healthcare.
11:00  to  11:30
Coffee Break and Presentation Room conversion
Crowne Plaza Barcelona Fira Center
11:30  to  12:15
Plenary 3
Room - Rossini 1 & 2
Creating Hot Topic Companies in Europe
Europe has held its own in the race to bring new modalities to the marketplace. Bio€quity’s globally facing VCs now identify where the next wave of leading edge start-ups can be created in Europe, and what they will have to do to attract finance in the global competition for capital.
Plenary 4
Room - Vivaldi 1 & 2
Creating Conditions for Hot Spots in Europe
Creating magnet zones for science, talent and capital requires policy, regulatory, legal and regional leadership. A cross-section of public and private sector stakeholders assess the environment for building and sustaining high-impact zones for the life sciences in Europe.

12:15  to  13:45
Lunch
Crowne Plaza Barcelona Fira Center
13:30  to  14:45
CEO Workshop 9.0
Room - Rossini 1
C-Suite Management
Great science and technology eventually need great C-Suite leadership. When is it time to elevate or bring in C-Suite competence? How do you determine which C-Suite roles to fill from within and when is it time to go outside? And what characteristics and qualities makes someone a C-suiter? BioEquity's 9th CEO Workshop will explore these topics from a CEO, board and investor perspective.
Presenting Company Sessions
Room - Rossini 2
Next Wave Sessions
Room - Vivaldi 1
Presenting Company Sessions
Room - Vivaldi 2

15:00  to  16:15
Regional Host Session
Room - Rossini 1
Scaling Up Catalonia
The number of international investors in the BioRegion of Catalonia has doubled in just 2 years. Biocat, the Regional Host of Bio€quity Europe, showcases companies that typify the untapped opportunity for investment in one of Europe’s fastest-growing life science hubs.
Presenting Company Sessions
Room - Rossini 2
Next Wave Sessions
Room - Vivaldi 1
Presenting Company Sessions
Room - Vivaldi 2

16:30  to  17:45
China
Room - Rossini 1
An R&D Hot Spot for European Biotechs
China's regulatory reforms and its adoption of ICH standards have paved the way for Western innovators to extend their global R&D strategies to the second-largest pharma market. At the same time, European and Chinese interests are converging on many Hot Topics, including gene and cell therapies, genomics and digital science. This workshop, organized by BioCentury and BayHelix, examines how European biotechs should be thinking about China as a Hot Spot for accelerating global development.
Presenting Company Sessions
Room - Rossini 2
Next Wave Sessions
Room - Vivaldi 1
Presenting Company Sessions
Room - Vivaldi 2

18:30  to  19:00
Transport to Gala Event
19:00  to  22:30
Evening Gala Reception
Palau Reial de Pedralbes - Avinguda Diagonal, 686, 08034 Barcelona
Tuesday, May 21, 2019

07:45  to  09:00
Registration Opens
Crowne Plaza Barcelona Fira Center
Light Breakfast
Crowne Plaza Barcelona Fira Center

09:00  to  10:15
Workshop
Room - Rossini 1
Hot Topics; Hot Stocks
Euronext lays out the strategic value of raising capital on the public stock market -- including the ability to accelerate growth, boost a company's profile with stakeholders and provide liquidity for investors wanting buy or sell shares -- and shows how Euronext's TechShare pre-IPO program can help biotech companies take the next step. Including a Q&A session with Euronext executives.
Presenting Company Sessions
Room - Rossini 2
Next Wave Sessions
Room - Vivaldi 1
Presenting Company Sessions
Room - Vivaldi 2

10:30  to  11:30
Workshop
Room - Rossini 1
“Biotech in Europe: Scaling Innovation"
In a Q&A session, McKinsey & Co. partners provide details on the findings of their survey of European life science executives and investors.
Presenting Company Sessions
Room - Rossini 2
Next Wave Sessions
Room - Vivaldi 1
Presenting Company Sessions
Room - Vivaldi 2

12:00  to  14:00
Grab & Go Lunch
Crowne Plaza Barcelona Fira Center
13:15  to  14:45
Pre-Seed Showcase
Room - Rossini 1
Selected Pre-Seed companies present to a diverse panel of Bio€quity Europe "judges," who provide high-level feedback on the entrepreneurs' presentations, business plans and overall strategy.
Pre-Seed Showcase
Room - Vivaldi1
Selected Pre-Seed companies present to a diverse panel of Bio€quity Europe "judges," who provide high-level feedback on the entrepreneurs' presentations, business plans and overall strategy.

15:00  to  16:00
Closing Reception
Crowne Plaza Barcelona Fira Center
PRESENTERS

Presenting Company slots running out. Please email Eric Pierce to nominate your company.

Bio€quity Europe 2019 will be anchored by more than 80 investor-validated Presenting and Next Wave Companies. The financial community recognizes that the Presenting Companies are independently chosen by BioCentury based on rigorous criteria, including fundraising validation and upcoming milestones informed by the intelligence of the conference's leading sponsors.

 

  • Ability Pharma
  • Achilles Therapeutics
  • Adrenomed AG
  • Aelin Therapeutics
  • Aelix Therapeutics S.L.
  • Alkahest Inc.
  • Allecra Therapeutics GmbH
  • Allinky Biopharma
  • Amylon Therapeutics B.V.
  • Aniling
  • Artios Pharma
  • Asceneuron S.A.
  • Calypso Biotech B.V.
  • Cantargia AB
  • Cardior Pharmaceuticals GmbH
  • Cellestia Biotech AG
  • Complix N.V.
  • Confo Therapeutics N.V.
  • DCPrime B.V.
  • Depixus S.A.S.
  • EpimAb Biotherapeutics Inc.
  • eTheRNA immunotherapies N.V.
  • GammaDelta Therapeutics Ltd.
  • Genfit S.A.
  • Genkyotex S.A.
  • Glycardial Diagnostics
  • IDP Pharma
  • ImCheck Therapeutics S.A.S.
  • Immunic AG
  • Inivata Ltd.
  • iOnctura S.A.
  • IGEM Therapeutics Ltd.
  • ISA Pharmaceuticals B.V.
  • Laboratoris Sanifit S.L.
  • LNC Therapeutics
  • Mc2 Therapeutics As
  • Mimetas B.V.
  • MiNA Therapeutics
  • Minoryx Therapeutics
  • Mission Therapeutics Ltd.
  • NBE-Therapeutics AG
  • Novadip Biosciences
  • Numab Therapeutics AG
  • Oryzon Genomics S.A.
  • OxStem Ltd.
  • PDC*line Pharma
  • Pharvaris B.V.
  • Polyneuron Pharmaceuticals AG
  • ProteoDesign
  • Rewind Therapeutics
  • Scenic Biotech B.V.
  • Secarna Pharmaceuticals GmbH
  • Senolytic Therapeutics Inc.
  • Senti Biosciences Inc.
  • Storm Therapeutics Ltd.
  • Topas Therapeutics
  • Vaximm AG
  • Vaxxilon AG
  • VCN Biosciences
  • Virion Biotherapeutics Ltd.
  • Xbrane Biopharma Ab
  • ZeClinics
SPONSORS

ORGANIZERS

  • {title}
  • {title}

FOUNDING SPONSOR

  • {title}

INSIGHTS PARTNER

  • {title}

GOLD SPONSOR

  • {title}

SILVER SPONSORS

  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}

REGIONAL HOST COMMITTEE

  • {title}
  • {title}
  • {title}
  • {title}

REGIONAL HOST PLATINUM SPONSORS

  • {title}
  • {title}

REGIONAL HOST GOLD SPONSORS

  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}
  • {title}

SUPPORTING PARTNER

  • {title}